Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

Replacement Total Voting Rights

15 Jun 2023 11:00

RNS Number : 8654C
Supply @ME Capital PLC
15 June 2023
 

The following amendment has been made to the 'Exercise of Open Offer Warrants, issue of equity and total voting rights' announcement released on 13 June at 07:00 under RNS No 4683C.

 

The Company's total issued share capital was previously listed as 61,144,413,368. This has been corrected to 61,157,163,350.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES.

13 June 2023

Supply@ME Capital plc

(the "Company" or "SYME")

Exercise of Open Offer Warrants, issue of equity and total voting rights

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, is pleased to announce that, further to the issue of 320,855,008 warrants to certain qualifying shareholders who participated in its open offer which completed on 17 August 2022 (the "Open Offer Warrants"), holders of Open Offer Warrants have elected to exercise 12,749,982 Open Offer Warrants. Accordingly, the Company will issue 12,749,982 new ordinary shares of £0.00002 nominal value each ("Ordinary Shares"), and £8,287.11 will be received by the Company as a result of the exercise of such Open Offer Warrants.

The Company has made applications to the Financial Conduct Authority (the "FCA") and London Stock Exchange plc (the "LSE") to have 12,749,982 new Ordinary Shares admitted to listing on the standard segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE, respectively, with admission expected to occur on or around 14 June 2023 ("Admission").

Following Admission, 235,751,597 Open Offer Warrants will remain outstanding, and the Company's issued share capital will comprise 61,157,163,350 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contact information:

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

MHP Group, SupplyME@mhpgroup.com

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREANKSFSKDEEA
Date   Source Headline
7th Dec 20204:36 pmRNSPrice Monitoring Extension
30th Nov 20207:30 amRNSTrading Update
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
12th Nov 202011:05 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension
3rd Nov 20207:00 amRNSUAE Update: Official launch of the Shari’a project
30th Oct 20207:00 amRNSInventory Funding: Securitisation Issue Update
26th Oct 20207:00 amRNSPrice Monitoring Extension
22nd Oct 202011:05 amRNSSecond Price Monitoring Extn
22nd Oct 202011:00 amRNSPrice Monitoring Extension
22nd Oct 202010:09 amRNSStrategic Agreement to launch in The United States
12th Oct 202011:52 amRNSAppointment of New Auditor
9th Oct 20202:06 pmRNSSecond Price Monitoring Extn
9th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20202:05 pmRNSSecond Price Monitoring Extn
30th Sep 20202:00 pmRNSPrice Monitoring Extension
29th Sep 20209:00 amRNSPrice Monitoring Extension
28th Sep 20207:02 amRNSUpdate on Business Operations
25th Sep 202010:00 amRNSDirector/PDMR Shareholding
25th Sep 20207:00 amRNSStatement regarding Orchestra Group Call Option
24th Sep 202012:20 pmRNSHolding(s) in Company
24th Sep 202012:20 pmRNSDirector/PDMR Shareholding
24th Sep 20209:05 amRNSSecond Price Monitoring Extn
24th Sep 20209:00 amRNSPrice Monitoring Extension
21st Sep 20209:06 amRNSSecond Price Monitoring Extn
21st Sep 20209:00 amRNSPrice Monitoring Extension
21st Sep 20207:00 amRNSEUR 8bn Funding Agreement with Bank acquisition
17th Sep 20207:00 amRNSResponse to erroneous media article
10th Sep 202011:05 amRNSSecond Price Monitoring Extn
10th Sep 202011:00 amRNSPrice Monitoring Extension
10th Sep 20207:00 amRNSInventory Funding and Investor Update
8th Sep 20207:00 amRNSHolding in Company
8th Sep 20207:00 amRNSDirector/PDMR Shareholding
4th Sep 20207:00 amRNSAlliance with leading Italian SME Fintech Platform
28th Aug 20207:00 amRNSHolding in Company
28th Aug 20207:00 amRNSDirector/PDMR Shareholding
21st Aug 20209:05 amRNSSecond Price Monitoring Extn
21st Aug 20209:00 amRNSPrice Monitoring Extension
21st Aug 20207:00 amRNSHolding(s) in Company
21st Aug 20207:00 amRNSDirector/PDMR Shareholding
20th Aug 20209:05 amRNSSecond Price Monitoring Extn
20th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 202011:06 amRNSSecond Price Monitoring Extn
19th Aug 202011:00 amRNSPrice Monitoring Extension
19th Aug 20209:05 amRNSSecond Price Monitoring Extn
19th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20209:05 amRNSSecond Price Monitoring Extn
18th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.